~~<i id='5D4477C813'><strike id='5D4477C813'><tt id='5D4477C813'><pre id='5D4477C813'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

author：Wikipedia 2025-09-30 08:51:56 - browse：665

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease.

If things go well, Roche could pay Alnylam up to $2.8 billion in total.

Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug firms have struggled to one-up existing treatments for high blood pressure and high cholesterol that are now available as cheap generics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Orangutan used medicinal plant to treat wound, first time ever seen

Wikipedia

knowledge

hotspot

focus

AdobeOverthepasttwodecades,hundredsofhospitalmergershaveescapedfederalantitrustscrutinyandledtobothh

WSS

Microsoft's Peter Lee: Generative AI could help doctors be more human

Change Healthcare: What is it, why does its cyberattack matter?

Ancient Greek ideas underpin modern concepts of pregnancy

Cell therapy fails to slow type 1 diabetes, but safety is established

For AI in health care standards, federal regulators join with industry group

Florida health officials providing scant details on measles cases

Wikipedia

Wikipedia

Wikipedia

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Immune cells and nerve overgrowth may explain recurring UTI pain

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Medical bills so high, Medicare adding extra digits to claim forms

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Streamlined flu vaccines recommended by FDA advisory panel

Peter Hotez and the public health issue of online harassment

Element Biosciences CEO lays out genome sequencing strategy

Peter Hotez and the public health issue of online harassment

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

knowledge

Cell therapy fails to slow type 1 diabetes, but safety is established

Close Medicare's dangerous gaps in addiction treatment coverage

Bird flu in milk supply is likely coming from asymptomatic cows

Getting Alzheimer's drug Leqembi to patients can be a challenge

Harvard's David Sinclair gets blowback over aging

Health care needs a new profession: neuroimaging counseling

hotspot

hotspot

hotspot

focus